Department of Pharmacy Practice

College of Pharmacy
masthead

Larisa H. Cavallari

 Larisa H. Cavallari Larisa H. Cavallari, PharmD, BCPS, FCCP
Associate Professor
Hospital Pharmacy
Department of Pharmacy Practice
Email humma@uic.edu
Phone 312-996-0886
Fax 312-996-0379
Office 125A PHARM m/c 886
US Mail 833 South Wood Street, RM164 MC886, Chicago, IL 60612

Research Interests
Dr. Cavallari's research focus is in the area of pharmacogenomics, particularly how genetic variants relate to cardiovascular drug response. 

Education
2000 Fellowship in Cardiovascular Pharmacogenomics The University of Florida, Gainesville, Florida
1998 ASHP Accredited Pharmacy Practice Residency Veterans Affairs Medical Center, Memphis, Tennessee
1997 Doctor of Pharmacy The University of Georgia, Athens, Georgia in affiliation with The Medical College of Georgia, Augusta, Georgia
1991 Bachelor of Science in Pharmacy, Summa Cum Laude The University of Georgia, Athens, Georgia
1989 Pre-pharmacy Georgia Southern University, Statesboro, Georgia

Current UIC Appointments
2001 to present Associate Professor, Department of Pharmacy Practice
Member of the Graduate Faculty, College of Pharmacy

Representative Publications
  1. Cavallari LH, Langaee TY, Momary KM, Shapiro NL, Nutescu EA, Coty WA, Viana MAG, Patel SR, Johnson JA. Genetic and clinical predictors of warfarin dose requirements in African Americans. Clin Pharmacol Ther 2010;87(4):459-64.
  2. Limdi NA, Wadelius M, Cavallari L, Eriksson N, Crawford D, Lee MM, Chen CH, Motsinger-Rief A, Sagreiya H, Liu N, Wu AHB, Gage BR, Jorgensen A, Pirmohamed M, Shin JG, Suarez-Kurtz G, Kimmel SE, Johnson JA, Klein TE, Wagner MJ on behalf of the IWPC. Warfarin pharmacogenetics: VKORC1 genotype as predictive as haplotype across three racial groups. Blood 2010;115(18):3827-34.
  3. Cavallari LH, Perera M, Wadelius M, Deloukas P, Taube G, Patel SR, Aquino-Michaels K, Viana MA, Shapiro NL, Nutescu EA. Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans. Pharmacogenet Genomics 2012;22(2):152-8.
  4. Liu Y, Jeong HY, Takahashi H, Drozda K, Patel SR, Shapiro NL, Nutescu EA, Cavallari LH. Decreased warfarin clearance with the CYP2C9 R150H (*8) polymorphism. Clin Pharmacol Ther 2012;91(4):660-5.
  5. Bress A, Patel SR, Perera MA, Campbell RT, Kittles RA, Cavallari LH. Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans. Pharmacogenomics 2012;13(16):1925-35.

Click here to view Dr. Cavallari's on-line CV. PDF logo

Return to faculty list